Great Basin CEO, Ryan Ashton, to Speak at the equities.com Small-Cap Stars Conference

SALT LAKE CITY, Dec. 17, 2014 /PRNewswire/ -- Ryan Ashton, co-founder and CEO of Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, will speak at 2:10 p.m. EST, Dec. 18, at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in Times Square, New York.

The Company's presentation from the event will be available at http://client.irwebkit.com/gbscience/presentations and will be archived for 90 days.

About Great Basin Scientific

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies.  The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company's website at www.gbscience.com. 

Media Contact:
Martina Schwarzkopf, Ph.D.
Russo Partners, LLC
212.845.4292
[email protected]

Investor Relations Contact:
Bob Yedid
ICR
646.277.1250
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/great-basin-ceo-ryan-ashton-to-speak-at-the-equitiescom-small-cap-stars-conference-300010540.html

SOURCE Great Basin Scientific, Inc.

Related Links

http://www.gbscience.com